Beyond glycemic control: cardiovascular and kidney benefits of GLP-1 receptor agonists and the dual GIP/GLP-1 receptor agonist tirzepatide: a narrative review.
A recently indexed PubMed record relevant to peptide research. The displayed date may reflect indexing rather than final print publication. Review the original citation and study limitations.
Open original source ↗Collected Nov 1, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.